platinum has been researched along with Fanconi Anemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Hong, WX; Liu, JS; Liu, ZQ; Mo, JL; Xiao, Q; Yin, JY | 1 |
| Lou, G; Mi, W; Qi, R; Tian, S; Xing, L; Zhang, C; Zhang, Y | 1 |
2 other study(ies) available for platinum and Fanconi Anemia
| Article | Year |
|---|---|
Association of variations in the Fanconi anemia complementation group and prognosis in Non-small cell lung cancer patients with Platinum-based chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Fanconi Anemia; Female; Genotype; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Polymorphism, Single Nucleotide | 2022 |
The identification of six risk genes for ovarian cancer platinum response based on global network algorithm and verification analysis.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Cell Line, Tumor; Disease-Free Survival; DNA Polymerase III; Drug Resistance, Neoplasm; Fanconi Anemia; Fanconi Anemia Complementation Group A Protein; Fanconi Anemia Complementation Group G Protein; Female; Gene Expression Regulation, Neoplastic; Histone Demethylases; Homologous Recombination; Humans; Middle Aged; Ovarian Neoplasms; Platinum; RecQ Helicases; Risk Factors | 2020 |